# Ernexa Therapeutics Inc.: Form 8-K, filed Feb 13, 2025

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2025-02-13
- Accepted by EDGAR: Feb 13, 2025, 16:30 ET
- Period: 2025-02-07
- Accession: 0001493152-25-006446
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/

## Items reported

- Item 5.08: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/form8-k.htm

Filed Feb 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-006446. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.